Loading...
*  Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in...
Angiotensin Receptor Antagonists. Angiotensin II. Angiotensinogen. Antihypertensive Agents. Angiotensin II Type 1 Receptor ... Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in ... RAAS hyperactivity may be attenuated pharmacologically with angiotensin II receptor blockers (ARB) which in systemic ... 12 months post operative blockade of the angiotensin II receptor will accelerate LV and LA reverse remodelling, reduce filling ...
https://clinicaltrials.gov/ct2/show/NCT00294775?cond=%22Aortic+valve+stenosis%22&rank=19
*  Angiotensin II type 1 receptor blockers. - Semantic Scholar
3-9 With saralasin, it became possible to demonstrate that angiotensin II receptor blockade, alone or in combination with salt ... angiotensin II-like effects. The next major breakthrough in the understanding of the renin-angiotensin system was triggered by ... a nonselective peptidic antagonist of angiotensin II receptors. ... heart failure by a specific blockade of the renin-angiotensin ... the development of orally active angiotensin-converting enzyme (ACE) inhibitors.10-15 Studies performed with these agents ...
https://www.semanticscholar.org/paper/Angiotensin-II-type-1-receptor-blockers.-Burnier/47afacff33df8b6edb024487f655ef7788708f86
*  The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic...
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic ... an angiotensin II type 1 receptor blocker (ARB), on ambulatory BP profiles and renal function in hypertensive CKD patients. ... 1.50±1.37, P=0.005; urinary type IV collagen excretion, 0.87±0.42 vs. 1.48±0.87, P=0.014) despite comparable A/B ratios for the ... Furthermore, the A/B ratios of urinary protein, albumin and type IV collagen excretion in the olmesartan add-on group were ...
http://www.biomedsearch.com/nih/angiotensin-II-type-1-receptor/23154587.html
*  Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on...
... a lack of data on how to treat hypertensive patients with diabetes when treatment with medium doses of calcium channel blocker ... and angiotensin II type 1 receptor blocker (ARB) is... ... combined with angiotensin II receptor blocker in type 2 ... Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on ... Angiotensin II type 1 receptor blocker Calcium channel blocker Essential Hypertension Home blood pressure Type 2 diabetes ...
https://link.springer.com/article/10.1007%2Fs00380-018-1286-2
*  Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers | Bentham Science
Keywords: Angiotensin II type receptor blocker, cardiovascular disease, molecular structures, class-specific effects, molecule- ... Keywords:Angiotensin II type receptor blocker, cardiovascular disease, molecular structures, class-specific effects, molecule- ... Angiotensin II (Ang II) type 1 (AT1) receptor is a member of the G protein-coupled receptor superfamily and contains 359 amino ... Abstract:Angiotensin II (Ang II) type 1 (AT1) receptor is a member of the G protein-coupled receptor superfamily and contains ...
http://www.eurekaselect.com/108656
*  Angiotensin II type 1 receptor blockers lower IOP in mice and reduce TGFβ signaling in retinal ganglion cells | IOVS | ARVO...
Purpose : Angiotensin II type 1 receptor blockers (ARBs) are commonly used to treat systemic hypertension. In addition to ... Angiotensin II type 1 receptor blockers lower IOP in mice and reduce TGFβ signaling in retinal ganglion cells ... Angiotensin II type 1 receptor blockers lower IOP in mice and reduce TGFβ signaling in retinal ganglion cells ... Ralph J Hazlewood, John Kuchtey, Rachel W Kuchtey; Angiotensin II type 1 receptor blockers lower IOP in mice and reduce TGFβ ...
http://iovs.arvojournals.org/article.aspx?articleid=2641875
*  Angiotensin II Type 1 Receptor Blockers | Circulation- stonel.info
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev.1993;45:205-251.Medline ... An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers irbesartan and losartan. ... Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem.1995;270:18719-18722.Crossref ... Blood pressure effects of the angiotensin II receptor blocker, losartan. Arch Intern Med.1995;155:405-411.CrossrefMedline ...
http://stonel.info/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MTQ6ImNpcmN1bGF0aW9uYWhhIjtzOjU6InJlc2lkIjtzOjk6IjEwMy82LzkwNCI7czo0OiJhdG9tIjtzOjIzOiIvcGhhcm1yZXYvNjUvMi84MDkuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9
*  Altex - Angiotensin II Type 1 Receptor Blockers, Angiotensin-Converting Enzyme Inhibitors, ATC:C09CA07
Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). ... Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, ... Telmisartan is an orally active nonpeptide angiotensin II antagonist that acts on the AT1 receptor subtype. New studies suggest ... Telmisartan works by blocking the vasoconstrictor and aldosterone secretory effects of angiotensin II. ...
http://pharmacycode.com/Altex.html
*  The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes -...
... or angiotensin receptor blocker (ARB) may experience a decreased incidence of new-onset type 2 diabetes. ... The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes. 7 ... The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes. ... two trials), or heart failure (two trials), reductions in new-onset type 2 diabetes were maintained (0.79 [0.72-0.85], 0.76 [ ...
http://www.thaiendocrine.org/en/2017/08/07/the-impact-of-ace-inhibitors-or-angiotensin-ii-type-1-receptor-blockers-on-the-development-of-new-onset-type-2-diabetes/
*  A randomized controlled study to compare the effects of angiotensin II type 1 receptor blockers (telmisartan vs candesartan vs...
A randomized controlled study to compare the effects of angiotensin II type 1 receptor blockers (telmisartan vs candesartan vs ... A randomized controlled study to compare the effects of angiotensin II type 1 receptor blockers (telmisartan vs candesartan vs ... on the markers of cardiovascular risk in hypertensive patients with type 2 diabetes mellitus Next Previous ... on the markers of cardiovascular risk in hypertensive patients with type 2 diabetes mellitus Completed ...
http://adisinsight.springer.com/trials/700041375?error=cookies_not_supported&code=65c246fb-b801-4768-b74e-eae74cada74a
*  Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal...
Angiotensin II Type 1 Receptor Blockers. Molecular Mechanisms of Pharmacological Action. Protective Agents. Anticarcinogenic ... Drug: Antioxidant group Drug: Calcium Channel Blockers Drug: Angiotensin receptor blocker group Drug: Placebo Phase 4 ... Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal ... calcium channel blocker (Verapamil) and angiotensin receptor blocker (Lozartan) against shock wave induced renal injuries. ...
https://clinicaltrials.gov/ct2/show/NCT01675362?recr=Open&intr=antioxidants&rank=4
*  The Use of Angiotensin Receptor Blockers and the Risk of Cancer - Full Text View - ClinicalTrials.gov
Angiotensin Receptor Antagonists. Diuretics. Adrenergic beta-Antagonists. Antihypertensive Agents. Angiotensin II Type 1 ... The Use of Angiotensin Receptor Blockers and the Risk of Cancer. The safety and scientific validity of this study is the ... The primary objective of this study was to assess whether angiotensin blockers (ARBs) and telmisartan in particular, are ... Receptor Blockers. Molecular Mechanisms of Pharmacological Action. Natriuretic Agents. Physiological Effects of Drugs. ...
https://clinicaltrials.gov/ct2/show/NCT02215733?term=breast+AND+neoplasms&lup_s=07%2F23%2F2014&lup_d=30
*  Olmesartan, an angiotensin II receptor blocker, restores cerebral hypoperfusion in elderly patients with hypertension.
... an angiotensin II receptor blocker (ARB), on cerebral blood flow (CBF) in elderly and hypertensive subjects. Ten subjects with ... Angiotensin II Type 1 Receptor Blockers / adverse effects, therapeutic use*. Antihypertensive Agents / therapeutic use*. Blood ... We evaluated the effects of olmesartan, an angiotensin II receptor blocker (ARB), on cerebral blood flow (CBF) in elderly and ... 0/Angiotensin II Type 1 Receptor Blockers; 0/Antihypertensive Agents; 0/Imidazoles; 0/Organotechnetium Compounds; 0/Tetrazoles ...
http://www.biomedsearch.com/nih/Olmesartan-angiotensin-II-receptor-blocker/20434053.html
*  Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal...
Though the inhibition of the renin-angiotensin system is known to have beneficial effects on atherosclerosis, the exact ... 7868875 - Angiotensin ii type 1 receptor messenger rna levels in human blood cells of patients wi.... 7973905 - Reversible ... Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal ... The aim of this study was to determine the effects of angiotensin II receptor blockers (ARB) on the oxidative stress and ...
http://www.biomedsearch.com/nih/Impact-angiotensin-II-receptor-blocker/16940715.html
*  Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor...
To identify genes influencing blood pressure response to an angiotensin II receptor blocker, single nucleotide polymorphisms ... To identify genes influencing blood pressure response to an angiotensin II receptor blocker, single nucleotide polymorphisms ... Angiotensin II Type 1 Receptor Blockers / therapeutic use*. Benzimidazoles / therapeutic use. Blood Pressure / drug effects, ... 0/Angiotensin II Type 1 Receptor Blockers; 0/Benzimidazoles; 0/Diuretics; 0/Epithelial Sodium Channels; 0/GPR83 protein, human ...
http://www.biomedsearch.com/nih/Genomic-Association-Analysis-Identifies-Multiple/22566498.html
*  GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence - Full...
Angiotensin II. Angiotensinogen. Antihypertensive Agents. Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor ... GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence. The ... an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence. J Cardiovasc Med (Hagerstown). ... Multi-Center Study on the Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation ...
https://clinicaltrials.gov/ct2/show/study/NCT00376272?show_locs=Y
*  Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan ...
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Molecular Mechanisms of Pharmacological Action. ...
https://clinicaltrials.gov/ct2/show/NCT00219180
*  Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients - Full Text View -...
Angiotensin Receptor Antagonists. Antihypertensive Agents. Angiotensin II Type 1 Receptor Blockers. Molecular Mechanisms of ... Although angiotensin receptor blockers (ARBs) are effective for patients with diabetes and chronic kidney disease in reducing ... Suzuki H, Kanno Y, Sugahara S, Ikeda N, Shoda J, Takenaka T, Inoue T, Araki R. Effect of angiotensin receptor blockers on ... Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients. The safety and ...
https://clinicaltrials.gov/show/NCT00530595
*  Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension - Full Text View - ClinicalTrials.gov
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Anti-Arrhythmia Agents. Diuretics. Natriuretic ... Calcium Channel Blockers. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasodilator Agents. ... Therapy with a fixed-dose combination of two active medications represents two drugs). ... Stage 2 Systolic Hypertension Drug: valsartan, amlodipine, HCTZ Drug: Losartan, HCTZ followed by valsartan, amlodipine, HCTZ ...
https://clinicaltrials.gov/show/NCT00931710
*  Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension - Full Text View - ClinicalTrials.gov
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. To Top. *For Patients and Families ... Calcium Channel Blockers. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasodilator Agents. ... Time Frame: 24±2 weeks ]. Percentage of patients achieving target blood pressure SBP/DBP ,140/90 mmHg is a key secondary ... Time Frame: baseline and 24±2 weeks ]. The primary endpoint is the mean blood pressure change SBP from baseline after 24±2 ...
https://clinicaltrials.gov/ct2/show/study/NCT01316419?term=%22High+Blood+Pressure%22&lup_s=08%2F15%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14&show_locs=Y
*  FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry) - Full Text View - ClinicalTrials...
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Molecular Mechanisms of Pharmacological Action. ... Calcium Channel Blockers. Membrane Transport Modulators. Vasodilator Agents. Tocolytic Agents. Reproductive Control Agents. ... Type 1 diabetes mellitus. *Known cardiovascular disease including history of angina pectoris, heart failure, history of ... Treated with other antihypertensive medication except diuretics or beta-blockers. * ...
https://clinicaltrials.gov/ct2/show/NCT01071122?term=%22High+Blood+Pressure%22&lup_s=01%2F26%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14
*  Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension - Full Text View - ClinicalTrials.gov
Note: Subjects with Type I or Type II diabetes controlled with insulin, diet or oral hypoglycemic agents on a stable dose for ... Calcium Channel Blockers. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasodilator Agents. ... Uncontrolled Type I or Type II diabetes defined as HbA1c ,9.0%. Diabetics must have documentation of HbA1c within 6 months of ... A history of New York Heart Association Class I or II CHF may be exclusionary at the discretion of the investigator. ...
https://clinicaltrials.gov/ct2/show/NCT00649389
*  DIabetic Retinopathy Candesartan Trials. - Full Text View - ClinicalTrials.gov
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Molecular Mechanisms of Pharmacological Action. ... Genetics Home Reference related topics: Type 1 diabetes MedlinePlus related topics: Diabetes Type 1 Diabetic Eye Problems ... This study is part of the DIRECT Programme also including a primary prevention study of diabetic retinopathy in type 1 diabetes ... Male or female aged 18 - 55 years with type 1 diabetes diagnosed before age of 36 years and in need for continuous insulin ...
https://www.clinicaltrials.gov/ct2/show/NCT00252720?term=DIRECT+candesartan&rank=1
*  Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age - Full Text View - ClinicalTrials.gov
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Diuretics. Natriuretic Agents. Physiological Effects ... Patients taking any of the following concomitant medications following screening: Renin-angiotensin receptor(RAAS) blockers ... Calcium Channel Blockers. Membrane Transport Modulators. Molecular Mechanisms of Pharmacological Action. Vasodilator Agents. ... Current diagnosis of heart failure (New York Heart Association Class II-IV) ...
https://clinicaltrials.gov/show/NCT01365481
*  Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients. - Full...
Angiotensin II Type 1 Receptor Blockers. Angiotensin Receptor Antagonists. Molecular Mechanisms of Pharmacological Action. ... Study Type:. Interventional Study Design:. Intervention Model: Single Group Assignment. Masking: None (Open Label). Primary ... After 1-week screening period, all of the eligible patients receive valsartan 80mg/day for 2 weeks, then the dosage will be ... Each subject will receive HBPM at baseline, week 2, week 6 and week 10 respectively.For baseline HBPM, it was performed in the ...
https://clinicaltrials.gov/ct2/show/NCT01541189